The ROE as of November 2024 (TTM) for Acer Therapeutics Inc. (ACER) is 56.36%

According to Acer Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is 56.36%. This represents a change of 0.15% compared to the average of 56.27% of the last 4 quarters.

Acer Therapeutics Inc. (ACER) Historical ROE (quarterly & annually)

How has ACER ROE performed in the past?

The mean historical ROE of Acer Therapeutics Inc. over the last ten years is -22.88%. The current 56.36% ROE has changed -346.30% with respect to the historical average. Over the past ten years (40 quarters), ACER's ROE was at its highest in in the December 2021 quarter at 256.48%. The ROE was at its lowest in in the September 2021 quarter at -151.22%.

Acer Therapeutics Inc. (ACER) ROE by Quarter and Year

Discovering the peaks and valleys of Acer Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acer Therapeutics Inc. (ACER) Average ROE

How has ACER ROE performed in the past?

The current ROE of Acer Therapeutics Inc. (ACER) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Acer Therapeutics Inc. (ACER) ROE vs. Peers

How is ACER’s ROE compared to its peers?

Acer Therapeutics Inc.’s ROE is less than NRx Pharmaceuticals, Inc. (0%), less than Pasithea Therapeutics Corp. (127.35%), greater than SAB Biotherapeutics, Inc. (-15595.10%), greater than Lexaria Bioscience Corp. (-94.37%), greater than Navidea Biopharmaceuticals, Inc. (-82.80%), greater than ZyVersa Therapeutics, Inc. (-173.56%), greater than Biodexa Pharmaceuticals Plc (-25512.50%), greater than Oncorus, Inc. (-101.74%), greater than Kiromic BioPharma, Inc. (-82.19%), less than YS Biopharma Co., Ltd. (327.18%), greater than BiomX Inc. (-44.72%), greater than Avenue Therapeutics, Inc. (-122.65%), greater than Hoth Therapeutics, Inc. (-473.61%), greater than Revelation Biosciences, Inc. (-89.69%), greater than NeuroBo Pharmaceuticals, Inc. (-311.33%), greater than Virax Biolabs Group Limited (-189.12%), greater than null (-115.10%),

Build a custom stock screener for Acer Therapeutics Inc. (ACER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acer Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acer Therapeutics Inc. (ACER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acer Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.